SHAREHOLDER ALERT: Brower Piven Encourages Investors Who

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Zimmer Biomet Holdings, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit – ZBH

STEVENSON, Md., Dec. 28, 2016 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Indiana on behalf of purchasers of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) (“Zimmer” or the “Company”) securities during the period between September 7, 2016 and October 31, 2016, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation have until January 31, 2017 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court.  The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action.  The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Zimmer securities during the Class Period.  Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.  No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that supply chain problems led to a decrease in order fulfillment rates, most notably within Zimmer’s knee and hip portfolios and the Company would not achieve its revenues and profit forecast.

According to the complaint, following an October 31, 2016 press release and conference call disclosing that sales weakness stemming from a change in the supply chain infrastructure, which led to shortfalls in the availability of implants and instrument sets during the quarter, the value of Zimmer shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Zimmer securities purchased on or after September 7, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html .  You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616.  Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s.  If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice.  You need take no action at this time to be a member of the class.

CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 hoffman@browerpiven.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exploring the Expansion of Data Diode Solutions Market Growth

Updated Category News Views 238

Understanding the Data Diode Solutions Market The Data Diode Solutions Market is rapidly evolving, with significant growth observed over recent years. This market is projected to increase from its current valuation of millions to an anticipated valuation surpassing USD 1.29 billion by the year 2033. This upward trajectory is driven by a compound annual growth rate (CAGR)...

Continue Reading
D.R. Horton Surpasses Expectations Amidst Housing Supply Crunch

Updated Category News Views 294

D.R. Horton Surpasses Revenue and Profit Expectations D.R. Horton has recently reported remarkable first-quarter results that exceeded analysts' expectations for both revenue and profit. This achievement comes in the context of a continuous shortage of existing homes in the U.S. housing market, which has significantly boosted the demand for new home sales, even amidst...

Continue Reading
Sustainable Innovations on the MS Mitsui Ocean Fuji Cruise Ship

Updated Category News Views 290

Introduction to the MS Mitsui Ocean Fuji The cruise industry is evolving, and the MS Mitsui Ocean Fuji, a remarkable vessel, is at the forefront of this change. This Japanese cruise ship, operated by Mitsui O.S.K. Lines, is an impressive example of how modern technology can meet sustainable practices in marine operations. History and Transition of the Ship Originally...

Continue Reading
South Korea's Trade Deal with U.S.: Seeking Rational Terms

Updated Category News Views 265

South Korea's Trade Deal Approaches Negotiation Hurdles In the world of international trade, negotiations can swing between promise and peril. Recently, the South Korean President Lee Jae Myung has raised significant concerns regarding a proposed trade deal with the United States, valued at $350 billion. This deal, originally discussed with former President Donald Trump,...

Continue Reading
Cullinan Therapeutics' CLN-049 Gains FDA Fast Track Approval

Updated Category News Views 141

Cullinan Therapeutics' New Milestone in Cancer Treatment Cullinan Therapeutics, Inc., a clinical-stage biopharmaceutical company, has recently received a significant boost in its fight against acute myeloid leukemia (AML). The U.S. Food and Drug Administration (FDA) has awarded Fast Track designation to its investigational drug CLN-049. This crucial milestone allows for...

Continue Reading